<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 314 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page313.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=314">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 314 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 314</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=314"><img src="../thumb/314.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.12                                                        2020-04 / 277
       sympts., jaund., rash, scler.icterus. Less freq: Abnorm. dreams,   poss. for those agents extens.metabol.by CYP3A, card. & neurolog.  or suspect. HVB/C, no dos.recomm.for itraconazole avail. theref.seek
       amnes., confus., somnol., abnorm. gait, allerg.react., anorex., incr.  events with disopyram./mexilet./ nefazodone/ fluoxet., desipramine   alt.antifung., rash report.with efavirenz & clarithromycin theref.con-
       appet., decr.weight, weight gain, anx., depress., sleep disord., ar-  AUC incr., didanosine C max & AUC reduc., ketoconazole mean-half   sid.alt.eg.azithromycin, combinat.with other macrolides not stud.
       thralg., musc.atrophy, myalg., myopathy, chest pain, fev., malaise,   life incr., AUC of sulfamethoxazole reduc.and of trimethoprim incr.,   Interactions: Reduc.NNRTI conc.with St John’s Wort expect.,
       dry mouth, dysgeus., flatul., gastrit., pancreatit., stomatit.aphthous,   mean C max & AUC of ethinyl oestradiol reduc., AUC of theophylline   poss.addit.CNS effs.with alcoh. /psychoact.meds., meds.induc.
       abdom.distens., dyspn., gynaecomast., haematur., pollakiur., protein-  decr., plasma conc.decr.with concom.St John’s Wort, alprazolam C max   CYP3A4 activ.incr. elimin, ser.conc.of emtricitabine/tenofovir incr.
       ur., kidn.pain, nephrolithias., hepatit., hepatosplenomeg., hypertens.,   decr., amprenavir/indinavir/ digoxin/ nelfinavir/rifabutin/saquinavir/   by acyclovir/adefovir dipivoxil/cidofovir/ ganciclovir/ valacyclovir/
       syncope, oed., palpitat., vasodil., lipodystrophy, alopec., eczema,   sildenafil/ tadalafil/ vardenafil/trazodone/vincristine/ vinblastine/   valganciclovir, conc.of emtricitabine/ tenofovir/concom.med incr.
       prurit., urticar., vesiculobull.rash, Stev.-Johns.syndr., toxic epiderm.  fluticasone propionate conc. incr., bosentan C max & AUC incr., bu-  with concom.drugs compet. for act.tubul.secret./decr.ren.funct,
       necrolys., eryth. mutiforme. Ritonavir: Freq: Abnorm.LFT, abdom.   propion lev.decr., buspirone lev.elev., clarithromyc.metabol.inhibit.,   tenofovir incr.didanosine plasma conc., efavirenz decr. amprenavir
       pain, diarrh., N&V, dry mouth, dyspeps., eructat., flatul., loc.throat   ritonavir C max & AUC incr.by delavirdine, AUC incr. with concom.  ser.conc., efavirenz & tenofovir decr.atazanavir conc., atazanavir
       irrit., mouth ulc., anorex., hyperlipem., weight loss, anx., insomn.,   efavirenz & efavirenz AUC incr., fusidic acid & ritonavir conc.incr.if   incr.tenofovir conc, efavirenz decr.indinavir conc., tenofovir conc.
       asthen., fev., pain, circumor.paresthes., headache, periph.paresthes.,   admin.concom., methadone/ warfarin conc.decr., voriconazole AUC   incr.with lopinavir/ritonavir combinat., tenofovir decr.lopinavir conc.,
       taste pervers., dizzin., hyperesthes., paresthes., somnol., incr.cough,   decr., zidovudine AUC/C max decr., tobacco decr AUC  poss.ritonavir & efavirenz conc. decr.with ritonavir, poss.saquinavir
       maculopapul.rash, prurit., rash, sweat., myalg. Less freq: Arthalg.,   conc. decr., poss.didanosine conc.decr., warfar.plasma conc.incr./
       arthros., back/fac./neck pain, joint disord., musc.cramps/weakn.,   RIZENE, (Unicorn) Adcock Ingram Ltd [P/S]  decr., carbamazepine/ phenytoin/ phenobarbit. & efavirenz conc.
       myosit., neck rigid., rhabdomyolys., twitch., pharyngit., vasodilat.,   Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-  decr.with these anticonvuls., sertraline/ itraconazole/ ketocona-
       abnorm.dreams, amnes., aphas., atax., convuls., grand mal convuls.,   marate 300 mg.  zole/ clarithromyc./rifabutin/Ca chan. block./ HMG-CoA reduct.in-
       incoordinat., neuralg., neuropathy, paralys., parosm., periph.neu-  Indications: Mono- or combinat.ther.for HIV-1 infect. in adults  hibit plasma conc.decr., methadone plasma lev.decr.result.in opiate
       ropathy, taste loss, trem., vis.ﬁeld defect, abnorm. electro-oculogr./  (S4) TABS, 47/20.2.8/0327  withdr. signs in HIV infect.IV drug users, rifampicin decr. efavirenz
       electroretinogr, abnorm. gait, chest pain, chills, flu syndr., malaise,   721720-001: 30, R240,00  conc., ethinyl oestrad.conc.incr.
       substern.chest pain., abnorm.vis., amblyop./blurr. vision, blepharit.,   Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may
       diplop., eye pain, irit., photophob., uveit., accident.inj., hypotherm.,   improv.CNS sympt. tolerabil.  SHILOVA, Aurobindo [P/S]
       acne, cont. dermatit., dry skin, eczema, fac.oed., folliculit., mollusc.   Contraindications: Concom.astemizole/bepridil/ cisapride/ mi-  Valaciclovir
       Contagios., photosens.psorias., seborrh., urticar., vesiculobull.rash,   dazolam/pimozide/ triazolam/ergot derivat/ St John’s Wort., con-  Indications: Herpes zoster (shingles), recurr.genit. herpes.in im-
       agitat., confus., depress., emotion.lability, euphor., hallucinat., decr.   com.voriconazole, mod.-sev.ren.impairm., concom.meds/combinat.   munocompet.adult pts., prevent.of recurr. H.simplex infect.of skin
       libido, nervousn., personality disord., abnorm.think., allerg.reacts.,   contain lamivudine, safety & effic.in pts.less than 18 yrs.not est.,   & ano-genit. mucous membr., CMV infect.prophylax., CMV dis. &
       anaem., ecchymos., leukopen., lymphadenopathy, lymphocytos.,   pregn. & lactat.  other herpes vir.infect.prophylax.aft.organ transpl. in spec.risk cases.
       thrombocytopen., asthma, dyspn., epistax., hiccup, hypoventilat.,   Side effects: Efavirenz: Freq: Arthralg., myalg., dyspeps., ab-  (S4) TABS. 45/20.2.8/0590
       interstit.pneumon., lung disord., rhinitis., avitaminos., cachex., de-  dom.pain, pancreatit., diarrh., N&V, headache, dizzin., insomn.,   719995-001: 500 mg, 10, R219,54
       hydrat., oed., glycosur., gout, hypercholesteraem., periph.oed., lipod-  imp.concentrat., anx., agitat., nervousn., euphor., confus., somnol.,   719995-002: 500 mg, 30, R658,63
       ystrophy, cholangit., hepatit., hepatomeg., liv.damage, diabet. mellit.,   amnes., abnorm. think./ dream., severe depress., prurit., skin rash,   719995-003: 500 mg, 42, R921,99
       dysur., haematur., kidn.calcul./ fail./ pain, noctur., polyur., pyelone-  rais.liv.enzymes. Less freq.: Hypoaesthes., convuls., paraesthes.,   Dosage: Adults: Herpes zoster: 1 000 mg 3x/dly for 7 days.
       phrit., urethrit., urin.freq., urin.retent., ear pain, hear.impairm., incr.   nervousn., erythema multiforme, Stev.-Johns.syndr., photo-allerg.   Recurr.genit.herpes: Init. within 24 hrs.of S&S onset./dur.prodro-
       cerum., tinnit., vertigo., enlarg.abdom., abnorm.stools, bloody diarrh.,   dermatit., skin discolourat., palpitat., rais. ser. cholester./triglyc-  mal.per: 500 mg 2x/day x5 days.
       cheilit., colit., constip., dysphag., oesophagit., gastrit., gastroenterit.,   erid./amylases, tinnit., allerg. reacts, gynaecomast., redistrib./ac-  Prevent.of recurr.H.Simplex: Immunocompet. pts: 500 mg
       gastrointest.disord./haemorrh., gingivit., ileit., oral monilias., pan-  cumulat.of body fat, hypercholesterolaem., hypertriglyceridaem.,   once dly. or 500 mg as div.dos.of 250 mg 2xdly.in very freq.occurr.
       creatit., periodont.absc., rect.disord., tenesm., thirst, impot., penis   anorex., aggress.reacts., agitat., delus., emotion. lability, mania,   Immunocomprom. pts: 500 mg 2xdly.
                                                                  CMV infect.& dis.prophylax: Adults & adolesc. from 12 yrs: 2
       disord., palpitat., syncope, haemorrh., hypotens., migraine, periph.  neuros., paranoia, psychos., suicide, abnorm.coordinat., atax.,
       vasc. disord., postur.hypotens., tachycard., dehydrat., hypotens.,   convuls., hypoesthes., trem., abnorm.vis., dyspn., constip., malab-  000 mg 4xdly admin.as early as poss.post-transpl.& reduc.accord.
                                                                  to creat. clear. Durat.usual. 90 days but poss.extend.in high risk pts.
       syncope, ren.insufﬁc., menorrhag., MI, seiz.  sorpt., incr.hepat.enzymes, hepatit., flush., nail disorders, myopathy.
       Warnings and Special precautions: New onset/ exist.diab.  Freq.unknown.: Aggress. behav., suicid.thoughts/attempts, hal-  Contraindications: Acyclovir hypersens., safety in pregn.& lactat.
                                                                  not est., no data avail.for childr.
       mellit.exacerbat., hyperglycaem., allerg.reacts., incr.risk for.furth   lucinat., fatig., hepat.fail,, myopathy, malabsorpt. Emtricitabine &
       transamin.elev.in underly.hepatit.B/C or mark. transamin.elev.  Tenofovir: Freq.: Anorex., lact.acidos, anx., headaches, back pain,   Side effects: Ac.ren.fail., CNS effs., seiz., encephalopathy, bld.
                                                                  dyscras., leukocytoclast. vasculit., ac.hypersens. reacts.incl.ana-
       prior to init.treatm., pre-exist.mild liv.dis./liv.enzyme abnormal./   cough, rhinit., pneum., dyspeps., abdom.pain, diarrh., N&V, flatul.,
       hepatit., discont.ther.until pancreatit. excl.in cases of N&V/abdom.  rash, prurit. Less freq.: Dyspn., pneum., hepatotox., hyperpigmen-  phylax. /angioed., headache, decr.consciousn.in ren. insuffic.,
                                                                  dizzin., fatig., atax., coma, dysarthr., trem., psych.disords., vis.ab-
       pain/ elev.biochem. mark., ser.cortisol conc.decr.with concom. flu-  tat.of soles &/ or palms, maculopapul./vesiculobull. rash, urticar.,
       ticasone. , PDE 5 assoc.adverse events poss. incr., eval. for signs of   pancreatit., paraesthes., periph. neuropathy, insomn., dizzin., head-  normal., tachycard., hypertens., GI disturbs., hepatit., abnorm.LFT,
                                                                  jaund., fac.oed., skin reacts.incl.erythema multiform. /Stev.Johns.
       fat redistribut., CV risk assessm. with evid. of lipodystrophy, im-  ache, myalg., bone pain, osteomalac., arthralg., myopathy, abnorm.
       mune reconstit. syndr.where pts.whose immune syst. responds   dreams. Freq.unknown: Allerg.reacts., hypophosphataem., lact.  syndr./tox.epiderm. necrolys., alopec., photosens., arthralg., ren.
                                                                  insuff., dysmenorrh.
       may develop inflamm.respon.to indol./ resid. opportunist.infects.  acidos., dyspn., incr.liv. enzymes, hepatit., rash, osteomalac., ren.
       necessitat.furth.evaluat. & treatm., pts.to seek med.advice if ex-  insuffic./ fail., Fanconi syndr., proxim.tubulopathy, proteinur., incr.  Special precautions: Foet.abnormal.report.in rats, elderly, ren.
                                                                  funct.impairm., underly.ren.dis., potent. nephrotox.meds., maint.
       per.joint pain/ aches/stiffn./movem.diffic.as osteonecros. poss, op-  creatin., ac.tubul.necros., nephrogen. diabet.insipid., polyur., inter-  adeq.hydrat., discont. ther.if CNS adverse reacts.occur, other meds.
       portunist.infects.& other HIV complicat. may still devel., ARV ther.  stit. nephrit., neutropen., anaem., breast enlargem., depress., elev.  aff.ren.physiol., concom.meds.compet.with acyclovir for eliminat.
       will not prev.risk of transmiss. through sex.cont.& bld.contamin.&   bilirubin./pancreat.amylase/ser. gluc./ urine gluc., rais.serum amyl-  potent.incr.plasma lev.of one/ both meds., clinic.exper.limit.in pts.
       appropr. precaut.to contin., monit.vir.load/CD4 counts reg., dis-  ase/ liv.enzymes, hypophosphataem., fatig., nephrit, ren.impairm.,
       cont.if sev. rash/nephrolithias. develops, treatm.-emerg.hepatit./   Fanconi’s syndr., polyur., sweat. Efavirenz + Emtricitabine & Ten-  with advanc. cirrhos., no data on effic.if init.more than 24 hrs.aft.
                                                                  S&S onset in recurr.genit.herpes.
       transamin. elevat. in pts.co-infect.with hepatit.B/C, poss.incr.   ofovir: Freq: Sinusit., URTI, nasopharyngit., immune reconstit.syn-
       bleed. by haemophiliacs, pre-exist.conduct.syst. dis., meds.known   dr., depress., insomn., abnorm.dreams, somnol., headache, dizzin.,   Warnings: Thrombot./thrombocytopen.purpura/ haemolyt. uraem.
                                                                  syndr poss.result.in death report. in pts.with advanc. HIV dis./aft.
       to induc.PR-interv.prolongat., cholesterol./ triglycerid.monit, eval.  diarrh., N&V, rash, fatig. Freq.unknown.: Lab. abnormalit.relat.to
       for alternat. etiolog. in pts.with simultan.hyperbilirubinaem. with   fast.cholester./creat. kinase/ ser.amylase/alkaline phosphat/AST/  bone marr.& ren. transpl.
                                                                  Drug interactions: Cimetidine & probenec.decr. ren.excret., plas-
       hepat.transamin.elev., no long-term safety data avail. for pts.ex-  ALT/ haemoglob./ hyperglycaem./haematur./ neutrophils/ fast.tri-
       per.persist.elev.in bilirub.&gt; 5x ULN, consid.altern.antiretrovir.ther.if   glycerid./hypertriglyceridaem./ hypercholesterolaem./ insul.resist./   ma AUC’s of aciclovir & mycophenolate mofetil metabol.both incr.
                                                                  when admin. concom.
       jaund./scleral icterus assoc.with bilirub.elev.pres.cosmet. concerns,   hyperlactataem./ hyperlipidaem., Cushingoid appear., accumulat.
       dos.reduct.not recomm.as long-term effic. of reduc.dos. not est.,   of body fat, dorsocervic.fat enlargem.  SONKE EFAVIRENZ, Sonke [P/S]
       elderly, poss.CNS effs. may influence driv./machine operat., lact   Warnings and special precautions: Not indic. for treatm.of   Efavirenz.
       intol., recomm.dos.with saquinavir combinat.not est., therapeut.   chron.hepatit.B infect., safety & effic. not est.in HBV & HIV co-  Indications: In combinat.with other antiretrovir. agents for HIV-
       conc.monit.of system.lidoc., monit.for irinotecan/ tenofovir assoc.   infects., monit.hepat. funct. for sev.mnths.in pts.co-infect.with HIV   1 infect.adults, adolesc.& childr. weigh.13 kg and above.& / 3 yrs
       adverse effs.with concom.ther., ECG monit.recomm.with concom.   & HBV who discont.ther.& appropr.init.of anti-hepatit. B ther.poss.  & above.
       Ca chann.block.(diltiazem), monit.INR with concom. warfar., admin.2   necess., obesity & prolong. nucleoside use poss.risk fact.for lact.aci-  (S4) CAPS, A40/20.2.8/0507
       hrs.bef./1 hr.aft. concom. antacids/ buffer.meds., ketoconazole &   dos., liv. dis. risk fact., discont.in clinic./lab.find.suggest. lact. acidos./  709529-001: 200 mg, 90, R323,69
       itraconazole dos.&gt;200 mg/day when combin.with ritonavir, alt.non-  hepatotox., investig.childr.expos.in utero to nucleoside & nucleotide   (S4) TABS, A40/20.2.8/0508
       hormon.contracept.with ritonavir combinat.ther.  analog.for poss. mitochondr. dysfunct.in case of relev.S&S, discont.   709528-001: 600 mg, 30, R101,43
       Drug interactions: Atazanavir: Plasma conc.of drugs metabol. by   ther. until pancreatit.excl.in cases of N&V/abdom. pain/ elev.bio-  Dosage: Admin.in combinat.with a protease inhibit. & /nucleo-
       CYP3A4 (e.g.Ca chann.block./ HMG CoA reduct.inhibit.& immuno-  chem.mark., monit.liv.funct.with pre-exist. liv.dysfunct., cons.ther.  side analog reverse transcriptase inhibit. Admin.on empty stom-
       suppress.incr., plasma conc.decr.by other drugs that induc CYP3A4   interrupt./discont.if evid. of worsen.liv.dis.monit.liv.enzymes par-  ach., prefer.at bedt., consid.bedt.dos.dur.1  2-4 wks ther.& in pts.
                                                                                    st
       (e.g. rifampicin), drugs.inhibit.CYP3A4 incr. plasma conc., didanosine/  tic.in known/ suspect.hepatit.B/C infect.hist./concom. hepatotox   exper. neurologic.effs.
       efavirenz/ tenofovir/ nevirapine decr.expos.to atazanavir, saquinavir   meds., test for chron.hepatit.B bef.init. ther., sev.ac.exacerbat.of   Adults: Recomm.dos.: 600 mg once dly. Adolesc. & childr.(17
       expos. incr., ritonavir incr.expos to atazanavir., poss.indirect (uncon-  hepatit.B aft.discont., immed. risk vs.benefit eval.of cont.ther.when   yrs.& und): 600 mg at bedt. Use only in adults & childr.weigh.
       jugat.) hyperbilirubinaem. due to inhibit. of UGT with concom.indi-  ser. psych. sympts.exper., do not admin.in pts.with creatin. clear.&lt; 50   great.than or equal to 40 kg
       nav., incr.expos.to other protease inhibit. if co-administer., incr. ve-  ml/min, determ.creatin.clear. bef. init./dur.ther., avoid with concom./  Contraindications: Concom.terfenadine/ astemizole/ cisapride/
       rapamil ser.conc. amiodarone/syst. lidocaine & quinidine conc.incr.,   rec. nephrotox. agents, pts at risk of ren.impairm., antihistam./ cor-  midazolam/triazolam/ergot derivat.as ser./life threat.adverse effs.
       rifabutin expos.incr., reduc. irinotecan metabolism, diltiazem expos.  ticoster.for mild to mod.rash to improv. tol.& resolv.rash, discont.in   poss., pregn., safety in lactat.not est., childr.&lt;3 yrs./ weigh &lt;13 kg,
       incr., ac.ergot toxicity with concom. ergot derivat., incr.atorvastat.   case of sev. skin rash, monit. BMD in pts.with patholog.bone fract.   concom.St John’s Wort., sev.hepat. impairm./prev.liv.injury hist., fail.
       expos.,decr.plasma conc.with proton-pump inhibits., poss incr.conc   hist./at risk of osteopen., Ca & vit.D supplementat. poss.benefic.,   with efavirenz contain.antiretrov.treatm.
       of midazolam/triazolam, decr. plasma conc.with St.John’s wort., ant-  cholesterol./ triglycerid. monit, seiz.hist., period.plasma monit. of   Side effects: CNS effs., psych.sympts., weight gain /loss, aggrav.
       acids/ buffer. meds.reduc.plasma conc., expos.to warfar./ TCA’s incr.  anticonvuls.ther., eval.for signs of fat redistrib., immune reconstit.  depress., abnorm.dreams/co-ordinat., atax., convuls., paraesthes.,
       with potent.to prod.ser./life threat. events, trazodone plasma conc.  syndr., opportunist.infects & other HIV complicat.still poss., ther.  neuropathy, incr.appet., confus., imp.co-ordinat., impot., libido
       poss.incr., voriconazole alone poss.incr.plasma conc., PDE 5 inhibit.   not proven to prev.HIV transmiss.through sex.cont./bld.contam.,   changes, neuralg., periph.neuropathy, speech disords., vertigo, ab-
       conc.incr., plasma conc.decr.by H 2-recept. antagon., ciclosporin/  elderly, perf.pregn.test in women of childbear.age prior to init.ther.,   norm.vis., tinnit., flush., palpitat., tachycard., asthma, sinusit., dyspn.,
       tacrolimus/sirolimus plasma conc. incr, ser.cortisol conc.decr.with   barr.contracept.tog.with other methods recomm.dur.& for 12 wks.  URTI, GI disturbs., gastrit., gastro-enterit./oesophag. reflux, malab-
       concom. fluticasone., clarithromycin conc.incr.caus.poss. QTc prolon-  aft. discont. treatm, concom.didanosine/atazanavir or lopinavir/ ri-  sorpt., hepatit., hepat.enzyme incr., hepat. fail., immune allerg.liv.
       gat., ethinyl estradiol & norethindrone lev.reduc.. Ritonavir: Agents   tonavir & discont.if advers.effs.develop, addit. ritonavir.recomm.with   injury/fail., skin.rash incl. prurit., incr. sweat., erythema multiforme
       which incr.CYP3A activ. e.g.phenobarbital, carbamazepine, dexa-  concom. fosamprenavir/ ritonavir once dly., monit.INR with concom.   & Stev.John. syndr., urticar., folliculit., alopec., acne, seborrh., nail
       methasone, phenytoin, rifampin & rifabutin decr. ritonavir plasma   warfar., do not admin.concom.saquinavir as sole protease inhibit.,   disords., skin discolourat., arthralg./ myalg., myopathy, fatig., allerg.
       conc., therapeut.eff.of direct. glucuronidated agents lost, dos.reduct.   monit.liv enzym.with concom. meds. assoc.wih hepat.toxic./known   reacts., asthen., taste pervers., malaise, syncope, alcoh.intol., hot</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page313.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page309.html">309</a>&nbsp;&nbsp;&nbsp;<a href="page310.html">310</a>&nbsp;&nbsp;&nbsp;<a href="page311.html">311</a>&nbsp;&nbsp;&nbsp;<a href="page312.html">312</a>&nbsp;&nbsp;&nbsp;<a href="page313.html">313</a>&nbsp;&nbsp;&nbsp;<a href="page314.html">314</a>&nbsp;&nbsp;&nbsp;<a href="page315.html">315</a>&nbsp;&nbsp;&nbsp;<a href="page316.html">316</a>&nbsp;&nbsp;&nbsp;<a href="page317.html">317</a>&nbsp;&nbsp;&nbsp;<a href="page318.html">318</a>&nbsp;&nbsp;&nbsp;<a href="page319.html">319</a>
             </td>
             <td width="35%"><a href="page315.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page315.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
